To study lung fuction and residual lung damage in COVID 19 patients who recover from the infections.
Not Applicable
- Conditions
- Health Condition 1: A00-B99- Certain infectious and parasitic diseasesHealth Condition 2: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2021/10/037090
- Lead Sponsor
- Christian Medical College Vellore
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Adult inpatients (more than 18 years and older) with positive SARS-CoV-2 RNA detection (throat swab) results and diagnosed with COVID-19
2. Willing to sign informed consent
Exclusion Criteria
1. Patients not willing to consent or unable to come for follow-up.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Lung function paramenters: FEV1, FVC, TLC, RV, DLco, DLco/VA <br/ ><br>2.6 Min walk test parameters: 6 min walk distance, Distance Saturation Product, Lowest SPO2, Dyspnea Borg scale <br/ ><br>3.CXR/HRCT: Fibrosis, Consolidation, bronchiectasis etc. <br/ ><br>4.SGRQ: Respirtory symptoms, problems, treatment & activities <br/ ><br> <br/ ><br>Timepoint: 4 to 6 weeks, 3 months, 6 months
- Secondary Outcome Measures
Name Time Method ilTimepoint: nil